德康醫療 DXCM 深 滬
交易中 09-16 15:37:40 美东时间
70.21
+0.700
+1.01%
華盛通- 最 高71.52
- 今 開70.00
- 成交量 271.65万股
- 最 低 69.93
- 昨 收 69.51
- 總市值 271.01亿
- 52周最高 142.00
- 市盈率 靜 53.92
- 換手率 0.70%
- 52周最低 62.34
- 委 比 53.33%
- 總股本 3.86亿
- 歷史最高 164.863
- 量 比 0.92
- 振 幅 2.29%
- 歷史最低 1.6875
- 每 手 1
- 風險率 21.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Three ‘buys,’ three ‘sells,’ and a ‘hold,’ by Oppenheimer analysts
Oppenheimer analysts provided insights into seven stocks this morning in a note. Buy-rated stocks: Modine Manufacturing Co. (NYSE:MOD) – The stock continues to have a bullish slope. Tandem Diabetes Ca...
09-13 00:30
Analysts’ Top Healthcare Picks: Dexcom (DXCM), Ascendis Pharma (ASND)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
09-10 17:50
Oppenheimer lists best stock ideas into the 2024 U.S. elections
Oppenheimer & Co. has published a 2024 U.S. elections playbook featuring its best equity-market ideas to provide exposure to key policy proposals and issues under a federal government controlled by th...
09-09 23:31
秀洲两个项目获市重点研发计划项目立项
转自：嘉兴日报 ■记者 吴冰鑫 通讯员 卜银方 本报讯 创新驱动发展，激活产业动能。日前，2024年嘉兴市第二批重点研发计划项目立项名单公布，共立项1...
09-06 07:01
Abbott launches over-the-counter glucose monitor, Lingo
Abbott Laboratories (NYSE:ABT) on Thursday announced the market launch of Lingo, its first continuous glucose monitoring system available without a prescription. The North Chicago, Illinois-based MedT...
09-05 23:37
柏基成长型股票策略 | 半年度回顾
整理编辑|贝小塔 —— 公众号《一年打卡100场路演》 时间：2024年8月 内容：柏基成长型股票策略| 半年度回顾 一句话概况：柏基减仓了英伟达...
09-03 22:51
Dexcom’s Stelo Sees Strong Market Adoption: Justifying a Buy Rating
Wells Fargo analyst Larry Biegelsen has assigned their bullish stance on DXCM s...
09-02 19:06
快讯 | 德康医疗（DXCM）发布旗下第一款OTC连续性血糖监测仪Stelo。用户可以花99美元线上购买一个月的供应，也可以按月租89美元持续订阅（监测服务）。
德康医疗（DXCM）发布旗下第一款OTC连续性血糖监测仪Stelo。用户可以花99美元线上购买一个月的供应，也可以按月租89美元持续订阅（监测服务）。
08-27 07:36
Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients
DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a prescription. Designed for people with Type 2 diabetes and prediabetes, Stelo offers personalized glucose insights via smartphone without fingersticks. Purchase online for $99 per month.
08-26 23:39
